Comprehensive Healthcare Systems Inc (CHS) AI Stock Analysis

• Market Cap: C$14.18M
• Dividend Yield: N/A
• Average Volume (3M): 12.96K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.35
• Revenue Growth: 16.04%
• EPS Growth: -455.38%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.01
• Shares Outstanding: 17,948,122
• 10 Day Avg. Volume: 12,600
• 30 Day Avg. Volume: 12,958
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.13
• Price to Sales (P/S): 0.33
• P/FCF Ratio: 34.16
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 53 Neutral
• Price Target: C$0.80 ▲(38.28% Upside)

The score is held down primarily by high financial risk—deeply negative equity, ongoing net losses, and TTM cash burn—despite clear improvement in revenue scale and gross margin. Technicals are supportive with price above major moving averages and positive MACD, but overbought RSI/Stoch conditions temper the outlook. Valuation adds limited support given the negative P/E and no dividend yield provided.

Positive Factors

Revenue and Gross Margin Expansion

Sustained 3.5x revenue growth and margin expansion to ~61% indicate improving unit economics and scalable demand. Over a multimonth horizon, higher revenue base plus better gross margins materially raise the odds of operating leverage and a credible path toward positive operating income if sustained.

Improving Unit Economics

Progressive margin improvement from ~30% to ~61% reflects operational improvements or higher-value offerings, which are durable drivers of profitability. If maintained, richer gross margins protect cash flow, facilitate reinvestment, and reduce break-even revenue needed for long-term profitability.

Prior Positive Operating Cash Flow

Ability to generate positive operating and free cash flow in 2024 shows the business can be self-funding under certain conditions. This episodic cash generation signals an underlying model that can support capital needs without permanent reliance on dilution if management sustains revenue and margin trends.

Negative Factors

Deeply Negative Shareholders' Equity

Persistently negative equity denotes a stressed capital structure that limits financial flexibility, raises refinancing risk, and increases likelihood of dilutive capital raises. Over 2–6 months this constrains strategic options and can hamper investment in growth or M&A initiatives.

Return to Cash Burn

Reversion to negative operating and free cash flow after a prior positive year shows cash generation is inconsistent. This increases dependency on external financing and raises execution risk; sustained cash burn would pressure liquidity and could force dilutive financing within months.

Ongoing Unprofitability

A persistent negative EBIT/EBITDA and ~-27% net margin indicate the business has not yet achieved structural profitability. Without durable margin expansion or cost control, losses will continue to erode capital and impede reinvestment, making sustainable growth and self-funding challenging.

Comprehensive Healthcare Systems Inc Business Overview & Revenue Model

Company Description

Comprehensive Healthcare Systems Inc. develops customized healthcare administrative software solutions. It offers membership cards, disease management, pre-certification, claim processing, and bill payment services. The company also provides licensing and maintenance services. It serves unions and self-insured funds, insurance companies, third party administrators, hospitals, and healthcare consumers, as well as doctors, dentists, and practitioners. The company was founded in 2001 and is headquartered in Edison, New Jersey.

How the Company Makes Money

CHS generates revenue primarily through the sale of its healthcare management software and electronic health records solutions. These products are offered to healthcare providers, hospitals, and clinics on a subscription or licensing basis, providing a steady stream of income. Additionally, the company earns from consulting services, where it assists healthcare organizations in implementing and optimizing their systems. Significant partnerships with healthcare providers and technology firms further enhance their market reach and contribute to revenue growth.

Comprehensive Healthcare Systems Inc Financial Statement Overview

Summary

Revenue and gross margin improved materially (TTM revenue up ~3.49x vs prior annual period; gross margin ~61%), but the business remains unprofitable with negative EBIT/EBITDA and a sizable net loss (~-27% net margin TTM). The balance sheet is a major weakness with deeply negative stockholders’ equity, and cash flow quality is inconsistent with TTM returning to negative operating cash flow and negative free cash flow.

Income Statement

TTM (Trailing-Twelve-Months) revenue grew strongly (+3.49x vs. the prior annual period), and gross margin improved to ~61% (vs. ~55% in 2024 and ~30% in 2023), indicating better unit economics. However, profitability remains weak: TTM operating results are still negative (EBIT and EBITDA), and the company continues to post a meaningful net loss (about -27% net margin TTM). The loss profile has improved materially from 2022–2023, but earnings are not yet stable or consistently moving toward breakeven.

Balance Sheet

The balance sheet is the key pressure point: stockholders’ equity is deeply negative in both TTM and annual periods, which limits financial flexibility and typically raises refinancing/dilution risk. Total assets are relatively small versus the company’s debt load, and with negative equity, leverage indicators are hard to interpret cleanly but still point to a stressed capital structure. While total debt is lower than 2024, the company remains highly balance-sheet constrained.

Cash Flow

Cash generation is inconsistent. In 2024 the company produced positive operating cash flow and slightly positive free cash flow, but TTM (Trailing-Twelve-Months) flipped back to cash burn (negative operating cash flow and negative free cash flow). The cash outflow magnitude is not as severe as 2021–2022, yet the return to negative free cash flow suggests the business is not consistently self-funding, which increases reliance on external capital.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.16M	3.77M	3.84M	4.30M	4.50M	4.74M
Gross Profit	2.53M	2.06M	1.15M	1.40M	1.37M	2.07M
EBITDA	-696.93K	121.99K	-2.86M	-5.13M	-2.63M	-331.13K
Net Income	-1.13M	-607.73K	-3.58M	-5.11M	-4.93M	-63.14K
Balance Sheet
Total Assets	885.15K	938.55K	1.28M	2.11M	4.11M	276.08K
Cash, Cash Equivalents and Short-Term Investments	21.78K	11.03K	31.55K	542.64K	3.40M	264.35K
Total Debt	2.48M	3.59M	3.28M	1.96M	2.22M	3.80M
Total Liabilities	6.27M	10.19M	9.01M	5.26M	3.50M	11.88K
Stockholders Equity	-5.39M	-9.25M	-7.73M	-3.15M	602.59K	264.21K
Cash Flow
Free Cash Flow	-498.27K	36.31K	-1.23M	-4.04M	-3.28M	-65.05K
Operating Cash Flow	-297.81K	366.80K	-1.23M	-3.97M	-3.27M	-58.85K
Investing Cash Flow	-518.63K	-628.01K	0.00	-68.41K	215.14K	-11.73K
Financing Cash Flow	824.22K	245.07K	852.45K	1.04M	4.39M	3.44M

Comprehensive Healthcare Systems Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	68 Neutral	C$517.04M	159.66	1.45%	―	59.34%	-23.48%
CHS	53 Neutral	C$14.18M	-3.73	―	―	16.04%	-455.38%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ADK	50 Neutral	C$35.52M	-6.18	―	―	-48.53%	-9.66%
AIDR	48 Neutral	C$62.88M	-4.24	-207.53%	―	―	7.04%
UDOC	44 Neutral	C$12.09M	-2.43	―	―	―	48.94%
DMED	33 Underperform	C$7.64M	-4.83	―	―	―	-67.11%

Comprehensive Healthcare Systems Inc Corporate Events

Comprehensive Healthcare Systems Hires RedChip to Lead Investor Relations and Boost Market Visibility

Comprehensive Healthcare Systems Inc. has engaged RedChip Companies to lead its investor relations and strategic communications, reflecting the company’s drive to broaden its visibility among institutional and retail investors as it reports accelerating client wins, positive adjusted EBITDA, and ongoing enhancements to its Novus 360 SaaS platform. Under the agreement, RedChip will receive a monthly retainer, stock options, and a separate fee for a national media and TV ad campaign planned for the first quarter of 2026, a move that underscores CHS’s efforts to strengthen its capital markets profile and communicate its growth trajectory and platform scalability to the global investment community, subject to TSX Venture Exchange approval.

The most recent analyst rating on (TSE:CHS) stock is a Hold with a C$0.57 price target. To see the full list of analyst forecasts on Comprehensive Healthcare Systems Inc stock, see the TSE:CHS Stock Forecast page.

Comprehensive Healthcare Systems to Raise Up to $3.5 Million and Settle Debt Through Share Issuance

Comprehensive Healthcare Systems Inc. announced a non-brokered private placement of up to 7 million units at $0.50 per unit to raise as much as $3.5 million, with each unit comprising one common share and half a warrant exercisable at $1.00 for three years, to fund general working capital. The company also plans to settle approximately US$893,250 in liabilities by issuing up to 2,465,369 common shares at $0.50 per share, moves that collectively aim to strengthen its balance sheet and liquidity, subject to customary closing conditions and TSX Venture Exchange approval.

The most recent analyst rating on (TSE:CHS) stock is a Hold with a C$0.47 price target. To see the full list of analyst forecasts on Comprehensive Healthcare Systems Inc stock, see the TSE:CHS Stock Forecast page.

Comprehensive Healthcare Systems Wins 5-Year Benefits Platform Deal with Amalgamated Life

Comprehensive Healthcare Systems Inc. has signed a five-year agreement with Amalgamated Employee Benefits Administrators and Amalgamated Life Insurance Company to deploy its Novus360 administration platform across Amalgamated’s pension and employee benefits operations in the Taft-Hartley multi-employer union market. The contract, effective immediately, is expected to boost CHS’s annual revenue by roughly 25% over the term while maintaining historical cost ratios, strengthening its presence in the union and multi-employer benefits space and reinforcing its role as a key technology partner for integrated health and pension administration as Amalgamated modernizes and consolidates its systems.